|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Parkinson's Disease | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Parkinson Disease | |||||
| 3 | More general conditions related to this trial | ||||
| Basal Ganglia Diseases | |||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Movement Disorders | |||||
| Nervous System Diseases | |||||
| Neurodegenerative Diseases | |||||
| Parkinsonian Disorders | |||||
| 4 | Interventions listed in this trial | ||||
| Coenzyme Q10 | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Ubiquinone | |||||
| 6 | More general drug interventions related to this trial | ||||
| Growth Substances | |||||
| Micronutrients | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Vitamins | |||||
| 7 | Sponsors listed in this trial | ||||
| National Institute of Neurological Disorders and Stroke (NINDS) | |||||